Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?

Affiliations

¹ Department of Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
² Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Sjukhusbacken 10, Stockholm, Sweden. per.tornvall@ki.se.

Comment

Shams Y-Hassan et al. Clin Auton Res. 2018 Feb.

. 2018 Feb;28(1):133-134.

doi: 10.1007/s10286-017-0483-x. Epub 2017 Nov 27.

¹ Department of Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
² Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Sjukhusbacken 10, Stockholm, Sweden. per.tornvall@ki.se.

No abstract available

Comment on

Epidemiology, pathogenesis, and management of takotsubo syndrome.
Y-Hassan S, Tornvall P. Y-Hassan S, et al. Clin Auton Res. 2018 Feb;28(1):53-65. doi: 10.1007/s10286-017-0465-z. Epub 2017 Sep 15. Clin Auton Res. 2018. PMID: 28917022 Free PMC article. Review.
Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?
Madias JE. Madias JE. Clin Auton Res. 2018 Feb;28(1):131-132. doi: 10.1007/s10286-017-0482-y. Epub 2017 Nov 6. Clin Auton Res. 2018. PMID: 29110279 No abstract available.